1 year return (CAGR)
-92.45%
Eiger Biopharmaceuticals Inc Exchange (NASDAQ, USD)
EIGR
-
+0.33 (+18.84%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-79.89%
5 year return (CAGR)
-65.93%
10 year return (CAGR)
-53.29%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
3.03M
Price/Sales
0.19
Ent value
30.88M
Price/Book
-
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-15.03%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 1.61 |
| Daily high | 2.05 |
| Daily low | 1.61 |
| Daily Volume | 95K |
| 1y analyst estimate | 30.00 |
| Beta | 1.84 |
| EPS (TTM) | -50.76 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| EIGR | S&P500 | |
| Current price drop from All-time high | -99.98% | -0.99% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 2 Apr 2024 | 9 Mar 2009 |
| Avg drop from high | -88.57% | -10.68% |
| Avg time to new high | 103 days | 12 days |
| Max time to new high | 2282 days | 1805 days |
News
No items found